Currently submitted to: JMIR Serious Games
Date Submitted: Feb 16, 2026
Open Peer Review Period: Feb 17, 2026 - Apr 14, 2026
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Effects and regulatory factors of exergaming on glucose and lipid metabolism in children and adolescents: A Systematic Review and Meta-Analysis
ABSTRACT
Background:
Glucose and lipid metabolism are critically linked to the health outcomes of children and adolescents. Exergaming interventions represent a promising approach to promote physical activity engagement in this population. However, the effects of exergaming on glucose and lipid metabolism remain controversial. This systematic review aimed to synthesize and update the evidence on this topic.
Objective:
This meta-analysis aimed to evaluate the effects of exergaming on glucose and lipid metabolism in children and adolescents compared with control conditions, and to examine potential moderators of these metabolic outcomes.
Methods:
Following the PRISMA 2020 guideline, we searched PubMed, Web of Science, Scopus, Embase, and the Psychology and Behavioral Sciences Collection (EBSCO) from inception to October 2025. Standardized mean differences (Hedges g) were pooled using random-effects models. Subgroup analyses and meta-regression were conducted to examine potential moderators(eg, sex, age, BMI, and intervention type). Study quality was assessed using RoB 2, ROBINS-I and the PEDro scale, and the certainty of evidence was rated using the GRADE approach.
Results:
Ten trials (N=732) were included. Exergaming showed no significant pooled effects on glucose or insulin. For lipid outcomes, exergaming was associated with a small reduction in LDL-C (Hedges g ā0.27, 95% CI ā0.47 to ā0.07; P=.008; IĀ²=19%), whereas no significant overall changes were observed for TC, TG, or HDL-C. Exploratory subgroup and meta-regression analyses suggested that sex and intervention type may be associated with variability in effects, but these findings should be interpreted cautiously given the limited number of studies. The overall certainty of evidence was low.
Conclusions:
Exergaming may modestly reduce LDL-C in children and adolescents, but evidence does not support consistent improvements in other glycemic or lipid outcomes. Given the low certainty of evidence and limited data for effect modification, larger, well-designed trials with clearly reported exercise dose and metabolic endpoints are needed to confirm these findings and to identify subgroups most likely to benefit. Clinical Trial: OSF Registries 10.17605/OSF.IO/64FUS.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.